SEC Form 4 · accession 0001185185-15-003351
U.S. Stem Cell, Inc. · USRM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
William P Murphy Jr.
Director · 10% Owner
Period of report
Dec 11, 2015
Accepted (ET)
Dec 21, 2015 · 5:31 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001388319
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Dec 11, 2015 | C | 146 | $0.7494 | A | 43,795 | D | |
| Common StockF1 | Dec 14, 2015 | C | 1,250 | — | A | 45,045 | D | |
| Common StockF2 | Dec 15, 2015 | C | 400 | — | A | 45,445 | D | |
| Common StockF3 | Dec 16, 2015 | C | 4,250 | — | A | 49,695 | D | |
| Common StockF4 | Dec 17, 2015 | C | 950 | — | A | 50,645 | D | |
| Common StockF5 | Dec 18, 2015 | C | 1,300 | — | A | 51,945 | D | |
| Common Stock | holding | — | — | — | 5,226 | I | Spouse |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1$0.70 to $1.14
- F2$1.11 to $1.14
- F3$0.9995 to $1.4495
- F4$0.80 to $1.10
- F5$0.98 to $1.10